Auto Amazon Links: No products found.
Lynette McHendry’s journey over the past decade has been marked by a combination of difficult treatments, emotional challenges, and unwavering hope. Diagnosed at 37 with an aggressive form of breast cancer, Lynette faced not only the physical and emotional toll of the disease but also the frustration of limited treatment options in Northern Ireland. Despite these obstacles, she has demonstrated tremendous resilience, overcoming a diagnosis that once felt like a “death sentence” and advocating for better access to life-saving therapies.
Initially, Lynette found herself dissatisfied with the standard local care and sought further medical advice at The Royal Marsden Hospital in London. There, she underwent genetic testing, confirming she was BRCA1 positive, and was offered platinum-based chemotherapy—treatments not available on the NHS in Northern Ireland at the time. Reflecting on this, she explained, “I was at a disadvantage living in Northern Ireland as women like me did not have access to treatment such as platinum-based chemotherapy and PARP inhibitors which are particularly relevant for BRCA gene-mutated cancers.” Her struggle also spotlighted regional disparities in access to care, as she discovered that women elsewhere in the UK were receiving therapies unavailable to her.
Lynette’s experience fueled her determination to raise awareness and support others facing similar battles. She engaged actively with patient groups, BRCA research forums, and scientific communities, while also documenting her story in a book titled *Unbroken*. Through these efforts, she emphasized the importance of personalized treatment approaches, sharing how communication with other patients led her to switch from tamoxifen to platinum chemotherapy and incorporate PARP inhibitors in her therapy plan. Her fight continued beyond breast cancer itself, as the disease later spread to her brain, requiring two craniotomies and additional treatments, yet in 2018 she was declared to have No Evidence of Active Disease (NEAD), a status she has maintained since.
Experts like Professor McIntosh see Lynette’s story as a hopeful testament to ongoing progress in cancer care. He highlighted advancements in early diagnosis, personalized therapies, and expanded treatment options as reasons to expect improved outcomes for breast cancer patients in the future. Research conducted at institutions such as Queen’s University Belfast and Ulster University plays a global role in this progress. “All cancer research through the NI cancer trials network allows us to deliver clinical trials and clinical studies which looks at new drugs, radiotherapy, chemotherapy in cancer patients and specifically to see what works for what patients,” he said. According to Professor McIntosh, Northern Ireland continues to make significant contributions to the worldwide fight against cancer, fueled by research and clinical innovation
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.